Statements (21)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
medical device
|
| gptkbp:approvalYear |
2017
|
| gptkbp:approvedBy |
gptkb:Europe
|
| gptkbp:deliveredBy |
transfemoral
|
| gptkbp:feature |
repositionable
minimally invasive controlled deployment mechanical expansion |
| gptkbp:first_approval_year |
2013
|
| https://www.w3.org/2000/01/rdf-schema#label |
Lotus Valve
|
| gptkbp:indication |
severe aortic stenosis
|
| gptkbp:legalStatus |
withdrawn from market
|
| gptkbp:manufacturer |
gptkb:Boston_Scientific
|
| gptkbp:targetAudience |
patients at high surgical risk
|
| gptkbp:usedFor |
transcatheter aortic valve replacement
|
| gptkbp:valve_type |
bioprosthetic
|
| gptkbp:withdrawal_year |
2021
|
| gptkbp:withdrawn |
commercial reasons
complex delivery system |
| gptkbp:bfsParent |
gptkb:SAPIEN_transcatheter_heart_valve
|
| gptkbp:bfsLayer |
7
|